| gender |
237 |
|
|
|
0.4 |
| Female |
|
76 (32%) |
65 (33%) |
11 (27%) |
|
| Male |
|
161 (68%) |
131 (67%) |
30 (73%) |
|
| mr |
237 |
2,000,119,114 (1,001,091,962, 2,002,149,521) |
2,000,207,017 (1,000,989,704, 2,002,102,756) |
2,000,074,301 (1,001,774,894, 2,002,249,414) |
0.4 |
| study_id_7 |
207 |
128 (67, 192) |
138 (68, 195) |
110 (61, 160) |
0.13 |
| Unknown |
|
30 |
30 |
0 |
|
| sex |
193 |
|
|
|
0.8 |
| F |
|
59 (31%) |
51 (31%) |
8 (29%) |
|
| M |
|
134 (69%) |
114 (69%) |
20 (71%) |
|
| Unknown |
|
44 |
31 |
13 |
|
| bmi_at_time_of_first_line |
237 |
26 (23, 32) |
26 (22, 32) |
27 (24, 33) |
0.4 |
| hb_a1c_at_the_time_of_first_line |
223 |
5.90 (5.05, 6.80) |
5.85 (5.00, 6.80) |
6.30 (5.40, 6.70) |
0.4 |
| Unknown |
|
14 |
12 |
2 |
|
| on_chronic_anticoagulation_at_time_of_first_line_yes_1_no_0 |
237 |
122 (51%) |
101 (52%) |
21 (51%) |
>0.9 |
| if_yes_to_anticoagulation_which_type_choose_from_drop_down_list |
122 |
|
|
|
0.6 |
| eliquis |
|
66 (54%) |
56 (55%) |
10 (48%) |
|
| heparin |
|
2 (1.6%) |
1 (1.0%) |
1 (4.8%) |
|
| other |
|
1 (0.8%) |
1 (1.0%) |
0 (0%) |
|
| warfarin |
|
41 (34%) |
33 (33%) |
8 (38%) |
|
| xarelto |
|
12 (9.8%) |
10 (9.9%) |
2 (9.5%) |
|
| Unknown |
|
115 |
95 |
20 |
|
| also_on_chronic_suppressive_antibiotics_at_time_of_first_line_on_abx_for_6_weeks_yes_1_no_0 |
237 |
3 (1.3%) |
2 (1.0%) |
1 (2.4%) |
0.4 |
| end_stage_renal_disease_on_dialysis_pd_or_hd_at_time_of_first_line_yes_1_no_0 |
237 |
4 (1.7%) |
4 (2.0%) |
0 (0%) |
>0.9 |
| active_cancer_at_time_of_first_line_yes_1_no_0 |
237 |
9 (3.8%) |
8 (4.1%) |
1 (2.4%) |
>0.9 |
| if_yes_to_active_cancer_what_type_pick_from_drop_down_list |
55 |
|
|
|
>0.9 |
| 0 |
|
43 (78%) |
31 (74%) |
12 (92%) |
|
| Bladder cancer |
|
2 (3.6%) |
2 (4.8%) |
0 (0%) |
|
| Breast Ca |
|
1 (1.8%) |
1 (2.4%) |
0 (0%) |
|
| breast cancer |
|
1 (1.8%) |
1 (2.4%) |
0 (0%) |
|
| CLL, RCC |
|
1 (1.8%) |
1 (2.4%) |
0 (0%) |
|
| CML |
|
1 (1.8%) |
1 (2.4%) |
0 (0%) |
|
| hx of "skin cancer" |
|
1 (1.8%) |
1 (2.4%) |
0 (0%) |
|
| hx of colon cancer s/p resection |
|
1 (1.8%) |
1 (2.4%) |
0 (0%) |
|
| hx of rectal cancer in remission |
|
1 (1.8%) |
1 (2.4%) |
0 (0%) |
|
| lung |
|
1 (1.8%) |
0 (0%) |
1 (7.7%) |
|
| Lung Cancer |
|
1 (1.8%) |
1 (2.4%) |
0 (0%) |
|
| prostate cancer |
|
1 (1.8%) |
1 (2.4%) |
0 (0%) |
|
| Unknown |
|
182 |
154 |
28 |
|
| ivdu_hx_at_time_of_first_line_yes_1_no_0 |
237 |
4 (1.7%) |
3 (1.5%) |
1 (2.4%) |
0.5 |
| hiv_status_at_time_of_first_line_yes_1_no_0 |
237 |
|
|
|
0.8 |
| 0 |
|
215 (91%) |
176 (90%) |
39 (95%) |
|
| 1 |
|
4 (1.7%) |
4 (2.0%) |
0 (0%) |
|
| n/a |
|
13 (5.5%) |
12 (6.1%) |
1 (2.4%) |
|
| N/A |
|
5 (2.1%) |
4 (2.0%) |
1 (2.4%) |
|
| hepatitis_c_status_at_time_of_first_line_yes_1_no_0 |
237 |
|
|
|
0.5 |
| 0 |
|
218 (92%) |
178 (91%) |
40 (98%) |
|
| 1 |
|
4 (1.7%) |
4 (2.0%) |
0 (0%) |
|
| n/a |
|
10 (4.2%) |
10 (5.1%) |
0 (0%) |
|
| N/A |
|
4 (1.7%) |
3 (1.5%) |
1 (2.4%) |
|
| Treated |
|
1 (0.4%) |
1 (0.5%) |
0 (0%) |
|
| on_total_parenteral_nutrition_at_time_of_first_line_yes_1_no_0 |
237 |
0 (0%) |
0 (0%) |
0 (0%) |
|
| h_o_of_skin_diseases_if_no_list_as_0_if_yes_pick_from_drop_down_list |
7 |
|
|
|
>0.9 |
| eczema |
|
2 (29%) |
1 (20%) |
1 (50%) |
|
| other |
|
1 (14%) |
1 (20%) |
0 (0%) |
|
| psoriasis |
|
4 (57%) |
3 (60%) |
1 (50%) |
|
| Unknown |
|
230 |
191 |
39 |
|
| hx_of_bacteremia_prior_to_first_picc_proline_placement_yes_1_no_0 |
237 |
13 (5.5%) |
10 (5.1%) |
3 (7.3%) |
0.5 |
| if_yes_to_hx_of_bacteremia_prior_to_first_line_what_was_the_pathogen |
91 |
|
|
|
0.4 |
| 0 |
|
41 (45%) |
29 (41%) |
12 (60%) |
|
| Citrobacter roseri |
|
1 (1.1%) |
1 (1.4%) |
0 (0%) |
|
| Coag negative staph bacteremia |
|
1 (1.1%) |
1 (1.4%) |
0 (0%) |
|
| E. coli |
|
2 (2.2%) |
1 (1.4%) |
1 (5.0%) |
|
| E. Coli |
|
1 (1.1%) |
1 (1.4%) |
0 (0%) |
|
| Group A strep |
|
2 (2.2%) |
2 (2.8%) |
0 (0%) |
|
| Klebsiella |
|
1 (1.1%) |
0 (0%) |
1 (5.0%) |
|
| MSSA |
|
1 (1.1%) |
1 (1.4%) |
0 (0%) |
|
| N/A |
|
36 (40%) |
31 (44%) |
5 (25%) |
|
| Pseudomonas aeruginosa, MRSA |
|
1 (1.1%) |
0 (0%) |
1 (5.0%) |
|
| Staph aureus |
|
1 (1.1%) |
1 (1.4%) |
0 (0%) |
|
| Staphylococcus aureus |
|
1 (1.1%) |
1 (1.4%) |
0 (0%) |
|
| Staphylococcus caprae |
|
1 (1.1%) |
1 (1.4%) |
0 (0%) |
|
| unknown |
|
1 (1.1%) |
1 (1.4%) |
0 (0%) |
|
| Unknown |
|
146 |
125 |
21 |
|
| on_immunuosuppressant_therapy_at_time_fo_first_line_yes_1_and_no_0 |
237 |
|
|
|
0.3 |
| 0 |
|
229 (97%) |
190 (97%) |
39 (95%) |
|
| 1 |
|
4 (1.7%) |
3 (1.5%) |
1 (2.4%) |
|
| 1- Evrolimus |
|
1 (0.4%) |
1 (0.5%) |
0 (0%) |
|
| 1 (pred) |
|
2 (0.8%) |
2 (1.0%) |
0 (0%) |
|
| Plaquenil |
|
1 (0.4%) |
0 (0%) |
1 (2.4%) |
|
| if_yes_to_on_immunosuppresent_which_one_pick_from_drop_down_menu |
2 |
|
|
|
>0.9 |
| mycophenolate mofetil |
|
1 (50%) |
1 (100%) |
0 (0%) |
|
| Prograf (tacrolimus) |
|
1 (50%) |
0 (0%) |
1 (100%) |
|
| Unknown |
|
235 |
195 |
40 |
|
| picc_1_or_proline_2 |
237 |
|
|
|
0.7 |
| 1 |
|
156 (66%) |
130 (66%) |
26 (63%) |
|
| 2 |
|
81 (34%) |
66 (34%) |
15 (37%) |
|
| if_proline_site_placed_pick_from_drop_down_list |
113 |
|
|
|
>0.9 |
| IJ |
|
112 (99%) |
92 (99%) |
20 (100%) |
|
| subclavian |
|
1 (0.9%) |
1 (1.1%) |
0 (0%) |
|
| Unknown |
|
124 |
103 |
21 |
|
| which_antiseptic_was_used_to_clean_site_prior_to_place_first_line_choose_from_drop_down_list |
224 |
|
|
|
|
| alcohol+chlorohexidine |
|
224 (100%) |
187 (100%) |
37 (100%) |
|
| Unknown |
|
13 |
9 |
4 |
|
| line_dressing_covering_choose_from_drop_down |
3 |
|
|
|
|
| Tegaderm |
|
3 (100%) |
1 (100%) |
2 (100%) |
|
| Unknown |
|
234 |
195 |
39 |
|
| reason_line_was_removed |
237 |
|
|
|
<0.001 |
| death |
|
28 (12%) |
28 (14%) |
0 (0%) |
|
| discontinue home inotrope |
|
40 (17%) |
40 (20%) |
0 (0%) |
|
| heart transplant |
|
11 (4.6%) |
11 (5.6%) |
0 (0%) |
|
| Line infection |
|
41 (17%) |
0 (0%) |
41 (100%) |
|
| line not removed |
|
30 (13%) |
30 (15%) |
0 (0%) |
|
| LVAD |
|
4 (1.7%) |
4 (2.0%) |
0 (0%) |
|
| other |
|
43 (18%) |
43 (22%) |
0 (0%) |
|
| routine exchange |
|
40 (17%) |
40 (20%) |
0 (0%) |
|
| if_line_infection_then_pathogen_identity |
98 |
|
|
|
<0.001 |
| Acetobacter, Streptococcus, MSSA |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| bacteremia but no tip culture done; Staphylococcus epidermidis and Serratia liquefaciens |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Blood culture neg, Arm culture around picc +MRSA |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| changed to proline |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| cmo |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| concern for line infection; bcx remained negative; line tip never cultured |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Cultures -ve |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| DVT |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| E. coli |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| E. Coli bacteremia likely GI source. Replace line for concern of seeding. |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Enterobacter cloacae (BC+, Tip negative) |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Enterobacter cloacea bacteremia no tip culture but + bcx |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| for repositioning, it was then removed |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| GNR (Kalamiella piersonii). |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| GPC - tip not cultured; + blood cx. |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| gram negative bacteremia (bcx +, no line tip cx sent) - organism not specified |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| he wanted to stop it |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| improvement in symptoms |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| klebsiella - bcx no tip cx data |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Klebsiella aerogenes |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Klebsiella aerogenes biovar pneumoniae (BC+, no tip culture) |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Klebsiella bacteremia |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Klebsiella Oxycota, Enterobacterales, Pseudomonas aeruginosa |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Klebsiella pneumoniae (BC+, Tip negative) |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Lelliottia (Enterobacter amnigenus) amnigena (BC+, Tip negative) |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Line malfunction |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Line dislodgement |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| line found to be positioned into IVC |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| line infiltration |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Line malfunction |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| line tip cultured postive for Klebsiella |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| malfunc picc |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| malfunctioning picc line |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Malpositioning of picc |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| mrsa bacteremia - no line tip cx available; + bcx |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| MSSA |
|
3 (3.1%) |
0 (0%) |
3 (7.3%) |
|
| MSSA bacteremia no tip culture available but + bcx |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| n/a |
|
6 (6.1%) |
6 (11%) |
0 (0%) |
|
| n/A |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| N/A |
|
15 (15%) |
15 (26%) |
0 (0%) |
|
| needs date for death |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| No pathogen identified (clinically appearing to be infected) |
|
2 (2.0%) |
0 (0%) |
2 (4.9%) |
|
| not clear from documenation |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Patient left AMA and opted to not have pursue treatment |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| picc line changed unclear why - routine it seems |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Placement issues |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Polymicrobial GNR bacteremia |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Proteus mirabilis |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Pseudomonas aeruginosa (BC+, no tip culture) |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Pseudomonas aeruginosa bacteremia. Negative tip. Thought to be from line. |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Pseudomonas bacteremia |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| pt discomfort, switched to proline |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| pt wanted to be off of milrinone |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| pt wants to change from arm to chest for convenience |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| pt went CMO |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| removed due to sluggish blood return |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| septic arthritis, so they took it out, line itself wasn’t infected, Achromobacter xylosidans |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Serratia marcens |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Staph aureus |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Staph Aureus (MRSA) - BC+, no tip culture |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Staph aureus MSSA - blood cultures positive; tip culture never done |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Staph Epi |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Staph epidermidis |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Staph epidermidis bacteremia bcx + but no tip cuture available |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Staph epidermidis bacteremia no tip culture available but + bcx |
|
2 (2.0%) |
0 (0%) |
2 (4.9%) |
|
| Staphylococcus aureus |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Stenotrophomonas maltophilia bacteremia |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Strep pneumoniae bacteremia no tip culture available but + bcx |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Streptococcus mitis |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| Streptophomonas maltophilia |
|
1 (1.0%) |
0 (0%) |
1 (2.4%) |
|
| suspected, no growth |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| switched to proline unclear why |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| switched tp proline as pt developed esrd during first line requiring HD |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| unclear why it was changed, not due to infection |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Went to hospice and stopped inotropes but NO documention of death |
|
1 (1.0%) |
1 (1.8%) |
0 (0%) |
|
| Unknown |
|
139 |
139 |
0 |
|
| chronic_wounds_no_0_yes_choose_from_drop_down_list |
16 |
|
|
|
>0.9 |
| diabetic foot ulcers |
|
5 (31%) |
4 (36%) |
1 (20%) |
|
| other |
|
2 (13%) |
1 (9.1%) |
1 (20%) |
|
| pressure ulcers |
|
7 (44%) |
5 (45%) |
2 (40%) |
|
| venous ulcers |
|
2 (13%) |
1 (9.1%) |
1 (20%) |
|
| Unknown |
|
221 |
185 |
36 |
|
| repeat_iv_insertions_at_time_of_first_line_eg_hf_patients_who_go_to_bridge_clinic_and_receive_lots_of_infusions_yes_1_no_0 |
233 |
54 (23%) |
48 (25%) |
6 (15%) |
0.2 |
| Unknown |
|
4 |
2 |
2 |
|
| other |
15 |
|
|
|
>0.9 |
| *chronic appearing foot ulcer but not diabetic or osteo |
|
1 (6.7%) |
0 (0%) |
1 (50%) |
|
| chronic ostomy |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| fever |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| fungemia |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| line displaced |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| line exchanged, concern for "symptomatic blood return" |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| Line non-functioning |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| line was displaced |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| original right picc dislodged |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| pain at original line |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| patient is on Vemlidy for chronic hep b |
|
1 (6.7%) |
0 (0%) |
1 (50%) |
|
| pro-line accidentally cut |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| suspected infection, but only swelling |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| SVC stenosis |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| Thrombophlebitis |
|
1 (6.7%) |
1 (7.7%) |
0 (0%) |
|
| Unknown |
|
222 |
183 |
39 |
|